Back to today’s briefing

Story perspectives

Helex Secures $3.5 Million to Tackle Kidney Disease

10/31/2025

41 4

Summary

Story summary

Helex, a therapeutics startup founded in 2021, raised $3.5 million in seed funding led by pi Ventures, bringing total funding to over $6 million.
The funding will accelerate development of its lead candidate for Autosomal Dominant Polycystic Kidney Disease (ADPKD) and advance its LNP drug delivery system.
Helex is incubated at ASPIRE-BioNEST, University of Hyderabad, and plans to expand its pipeline to other kidney conditions.

1 of 1

Story summary

Helex, a therapeutics startup founded in 2021, raised $3.5 million in seed funding led by pi Ventures, bringing total funding to over $6 million.
The funding will accelerate development of its lead candidate for Autosomal Dominant Polycystic Kidney Disease (ADPKD) and advance its LNP drug delivery system.
Helex is incubated at ASPIRE-BioNEST, University of Hyderabad, and plans to expand its pipeline to other kidney conditions.